Advertisement
ALC vs BSX
Which Stock Would AI Choose? Alcon Inc. (ALC) vs. Boston Scientific Corporation (BSX) Stock Comparison
Key Takeaways
- Alcon Inc. (ALC) focuses on eye care products and surgical devices, while Boston Scientific Corporation (BSX) offers a broader portfolio of medical devices across cardiovascular and other therapeutic areas.
- In recent weeks, ALC has shown resilience amid analyst price target adjustments and new partnership announcements, trading near $68 with modest gains.
- BSX has faced pressure from earlier guidance revisions and segment-specific headwinds, with shares around $44 ahead of its Q2 2026 earnings release on July 29.
- Both companies operate in the healthcare sector with exposure to innovation-driven growth, though BSX's larger market capitalization reflects its diversified operations.
- Recent market activity highlights contrasts in momentum, with ALC benefiting from targeted expansions and BSX emphasizing share repurchases and clinical milestones.
- Relative performance reflects sector dynamics, with observable differences in stability and catalyst timing influencing short-term sentiment.
Introduction
Alcon Inc. (ALC) and Boston Scientific Corporation (BSX) represent two established players in the medical technology space, making them relevant for comparison among healthcare-focused investors and traders. ALC specializes in vision care, while BSX provides a wider range of interventional devices. This analysis examines their business models, recent performance trends, and market positioning to assist those evaluating relative opportunities within the sector. The comparison draws on verifiable developments from the past several weeks to highlight observable contrasts without forward-looking assumptions.
ALC Overview and Recent Performance
Alcon Inc. (ALC) develops, manufactures, and markets surgical equipment, pharmaceutical eye drops, and consumer vision care products for treating eye diseases and disorders. In recent market activity, the stock has traded near $68 following Q1 2026 results that showed sales growth of 10% on a reported basis. Developments in recent weeks include the opening of a second center with the Aravind Eye Care System and a non-exclusive collaboration with RxSight to develop adjustable intraocular lenses. Analyst actions have included several price target reductions, contributing to tempered sentiment, though the company maintains a focus on innovation in its core ophthalmic segments.
BSX Overview and Recent Performance
Boston Scientific Corporation (BSX) designs and manufactures less invasive medical devices used in cardiovascular, rhythm management, and other interventional procedures. In recent market activity, shares have traded near $44 amid earlier guidance adjustments and segment-specific pressures. Key developments include a $2 billion accelerated share repurchase agreement completed in May 2026 as part of a larger authorization, along with positive outcomes from clinical trials such as the FRACTURE IDE study for a coronary intravascular lithotripsy catheter. The company is scheduled to report Q2 2026 results on July 29, with consensus estimates pointing to EPS of $0.83 and revenue of $5.39 billion.
Trending AI Robots
Tickeron’s Trending AI Robots page curates a selection of high-performing AI trading bots from hundreds available on the platform. These bots trade thousands of different tickers using varied strategies, timeframes, and performance metrics tailored to current market conditions. Only the most suitable and top-ranked options based on backtested results, win rates, and risk-adjusted returns earn placement in this section. Available bots display ranges of historical performance statistics, including different profit factors and drawdown profiles, allowing users to explore options aligned with specific trading styles. The platform provides transparent data on each bot’s parameters for informed evaluation. Review the Trending AI Robots page for the latest curated selections.
Head-to-Head Comparison
Alcon Inc. (ALC) operates with a concentrated focus on ophthalmic products and procedures, exposing it to growth in elective eye surgeries and vision correction trends. Boston Scientific Corporation (BSX) maintains broader sector exposure through cardiovascular and structural heart devices, which can provide diversification but also sensitivity to procedural volume fluctuations. Recent momentum for ALC has been supported by partnership expansions, while BSX has emphasized capital returns via buybacks following prior guidance updates. Risk factors differ in emphasis, with ALC facing competitive pressures in its niche and BSX navigating device-specific regulatory and adoption considerations. Market sentiment reflects these distinctions, as ALC contends with multiple analyst revisions and BSX positions ahead of earnings with observable operational updates.
Tickeron AI Verdict
Based on observable factors such as trend consistency in recent weeks, stability metrics, and positioning relative to near-term catalysts, Tickeron’s AI would currently assign a higher probabilistic preference to Alcon Inc. (ALC) over Boston Scientific Corporation (BSX). ALC’s targeted expansions and sustained sales growth trajectory provide a steadier profile in the evaluated period compared to BSX’s guidance adjustments and upcoming earnings event. This assessment remains probabilistic and tied to verifiable recent activity rather than predictive claims.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ALC is a Hold and BSX is a Buy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
ALC’s FA Score shows that 1 FA rating(s) are green whileBSX’s FA Score has 0 green FA rating(s).
- ALC’s FA Score: 1 green, 4 red.
- BSX’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
ALC’s TA Score shows that 5 TA indicator(s) are bullish while BSX’s TA Score has 5 bullish TA indicator(s).
- ALC’s TA Score: 5 bullish, 4 bearish.
- BSX’s TA Score: 5 bullish, 4 bearish.
Price Growth
ALC (@Pharmaceuticals: Other) experienced а +4.27% price change this week, while BSX (@Medical/Nursing Services) price change was +7.71% for the same time period.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +5.64%. For the same industry, the average monthly price growth was +9.95%, and the average quarterly price growth was +6.67%.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +2.21%. For the same industry, the average monthly price growth was +0.58%, and the average quarterly price growth was -4.36%.
Reported Earning Dates
ALC is expected to report earnings on Nov 10, 2026.
BSX is expected to report earnings on Oct 28, 2026.
Industries' Descriptions
@Pharmaceuticals: Other (+5.64% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
@Medical/Nursing Services (+2.21% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
| ALC | BSX | ALC / BSX | |
| Capitalization | 35.3B | 74.5B | 47% |
| EBITDA | 2.54B | 5.49B | 46% |
| Gain YTD | -6.636 | -46.072 | 14% |
| P/E Ratio | 56.17 | 20.82 | 270% |
| Revenue | 10.6B | 20.6B | 51% |
| Total Cash | 1.66B | 1.45B | 114% |
| Total Debt | 5.25B | 11B | 48% |
ALC | BSX | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 20 | 29 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 38 Fair valued | 69 Overvalued | |
PROFIT vs RISK RATING 1..100 | 91 | 90 | |
SMR RATING 1..100 | 88 | 58 | |
PRICE GROWTH RATING 1..100 | 48 | 62 | |
P/E GROWTH RATING 1..100 | 17 | 98 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
ALC's Valuation (38) in the Hospital Or Nursing Management industry is in the same range as BSX (69) in the Medical Specialties industry. This means that ALC’s stock grew similarly to BSX’s over the last 12 months.
BSX's Profit vs Risk Rating (90) in the Medical Specialties industry is in the same range as ALC (91) in the Hospital Or Nursing Management industry. This means that BSX’s stock grew similarly to ALC’s over the last 12 months.
BSX's SMR Rating (58) in the Medical Specialties industry is in the same range as ALC (88) in the Hospital Or Nursing Management industry. This means that BSX’s stock grew similarly to ALC’s over the last 12 months.
ALC's Price Growth Rating (48) in the Hospital Or Nursing Management industry is in the same range as BSX (62) in the Medical Specialties industry. This means that ALC’s stock grew similarly to BSX’s over the last 12 months.
ALC's P/E Growth Rating (17) in the Hospital Or Nursing Management industry is significantly better than the same rating for BSX (98) in the Medical Specialties industry. This means that ALC’s stock grew significantly faster than BSX’s over the last 12 months.
| ALC | BSX | |
|---|---|---|
| RSI ODDS (%) | 1 day ago 62% | 1 day ago 26% |
| Stochastic ODDS (%) | 1 day ago 53% | 1 day ago 42% |
| Momentum ODDS (%) | 1 day ago 66% | 1 day ago 64% |
| MACD ODDS (%) | 1 day ago 56% | N/A |
| TrendWeek ODDS (%) | 1 day ago 58% | 1 day ago 55% |
| TrendMonth ODDS (%) | 1 day ago 56% | 1 day ago 55% |
| Advances ODDS (%) | 3 days ago 57% | 1 day ago 58% |
| Declines ODDS (%) | 8 days ago 55% | 15 days ago 55% |
| BollingerBands ODDS (%) | 1 day ago 62% | 1 day ago 45% |
| Aroon ODDS (%) | 1 day ago 40% | 1 day ago 54% |
Advertisement
ALC and
Correlation & Price change
A.I.dvisor indicates that over the last year, ALC has been loosely correlated with SYK. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ALC jumps, then SYK could also see price increases.
BSX and
Correlation & Price change
A.I.dvisor indicates that over the last year, BSX has been closely correlated with ISRG. These tickers have moved in lockstep 71% of the time. This A.I.-generated data suggests there is a high statistical probability that if BSX jumps, then ISRG could also see price increases.
| Ticker / NAME | Correlation To BSX | 1D Price Change % | ||
|---|---|---|---|---|
| BSX | 100% | +0.45% | ||
| ISRG - BSX | 71% Closely correlated | +0.01% | ||
| MMSI - BSX | 56% Loosely correlated | +0.10% | ||
| ALC - BSX | 49% Loosely correlated | -2.35% | ||
| NTRA - BSX | 45% Loosely correlated | +1.04% | ||
| MDT - BSX | 45% Loosely correlated | +0.09% | ||
More | ||||